BSE: 532488|NSE: DIVISLAB|ISIN: INE361B01024|SECTOR: Pharmaceuticals
News on Divis Laboratories
Sell SBI; buy Divis Labs: Sameet Chavan
3.23 pm | 05 Mar 2015 | Source: CNBC-TV18
Sameet Chavan of Angel Broking is of the view that one can sell State Bank of India and advises buying Divis Laboratories....
Here are some top trading ideas from Yogesh Mehta
2.26 pm | 04 Mar 2015 | Source: CNBC-TV18
Watch the interview of Yogesh Mehta of Motilal Oswal Securities with Ekta Batra & Reema Tendulkar on CNBC-TV18, in which he shared his readings and ou...
Motilal Oswal neutral on Divis Laboratories
5.48 pm | 19 Feb 2015 | Source: Moneycontrol.com
Motilal Oswal has maintained a 'Neutral' rating on Divis Laboratories with a target price of Rs 1910, in its research report dated January 31, 2015....
11 stocks you should keep an eye on: Emkay
3.53 pm | 11 Feb 2015 | Source: Moneycontrol.com
Emkay has come out with its 11 stock picks report. The research firm has recommended to buy Jagran Prakashan, PVR, UPL, GSK Consumer; accumulate Shopp...
Buy Divis Labs; target of Rs 2050: ICICIdirect
3.53 pm | 15 Jan 2015 | Source: Moneycontrol.com
ICICIdirect.com has recommended to buy Divis Laboratories in the range of Rs 1710-1735 for the target price of Rs 2050 with a stop loss of Rs 1556, in...
Quick Links for Divis Laboratories
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.